2026 Q2 -tulosraportti
UUTTA
2 päivää sitten
‧48 min
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 25.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 26.8. | ||
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 25.2. | ||
2025 Q3 -tulosraportti 24.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·57 min sitten · MuokattuApproximately 20 % more shares have been allocated, if I have understood correctly, at a price 12 % cheaper than the closing price 27.08 of 4,99. Purely mathematically, that should have resulted in a decrease of 2,4 %, which is 12 øre. I.e. price 4,87 before the benefits of the issue are taken into account.
·1 t sittenCapitalizing on the share rally: Raises 286 million. Nykode Therapeutics raises 286 million kroner after a strong stock market rally. The share issue was several times oversubscribed.
·1 t sittenGood news, the issue was oversubscribed several times. With only 12% discount, the price will probably adjust down a bit. But the finances are strengthened, and the development of the treatments could yield fantastic results. Then the price will probably move further up. Exciting months ahead.
·2 t sittenYou must not take everything written here at face value or as a "definitive answer", nor the comment about "down towards the issue price". "It all depends", if it's a distress issue, then yes, the price often but not always goes down towards the issue price, and often even below. If it's an offensive issue, it can go the opposite way. And this issue is more of an "offensive" character than a "Crisis". But there's no definitive answer either on whether it goes up or down based on that. I won't elaborate further here as I also have work to follow up on. But as I said, it seems many here unfortunately have no clue about stocks and the market, they just speculate wildly and spread opinions that unfortunately, directly and indirectly, cause harm because the wrong conclusions also live on. There is no definitive answer that the price will go all the way down to the issue, or as some believe, that you are almost obliged to sell at the issue price :o Read up a bit on what an issue is, and the different types of processes that have triggered the issues. Feel free to use GOOGLE AI which "unfortunately" gives much better answers than you'll find on the forum here.
You naturally have very good points. Many investors with good insight gladly wanted to participate in this share issue for 4.44. And the reason for that was NOT that they would sell out at 4.60. They have much higher expectations. I will be cautious about giving others advice regarding investments, but I still allow myself to ask; why sell now at a price that is 8% lower than yesterday?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q2 -tulosraportti
UUTTA
2 päivää sitten
‧48 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·57 min sitten · MuokattuApproximately 20 % more shares have been allocated, if I have understood correctly, at a price 12 % cheaper than the closing price 27.08 of 4,99. Purely mathematically, that should have resulted in a decrease of 2,4 %, which is 12 øre. I.e. price 4,87 before the benefits of the issue are taken into account.
- ·1 t sittenCapitalizing on the share rally: Raises 286 million. Nykode Therapeutics raises 286 million kroner after a strong stock market rally. The share issue was several times oversubscribed.
- ·1 t sittenGood news, the issue was oversubscribed several times. With only 12% discount, the price will probably adjust down a bit. But the finances are strengthened, and the development of the treatments could yield fantastic results. Then the price will probably move further up. Exciting months ahead.
- ·2 t sittenYou must not take everything written here at face value or as a "definitive answer", nor the comment about "down towards the issue price". "It all depends", if it's a distress issue, then yes, the price often but not always goes down towards the issue price, and often even below. If it's an offensive issue, it can go the opposite way. And this issue is more of an "offensive" character than a "Crisis". But there's no definitive answer either on whether it goes up or down based on that. I won't elaborate further here as I also have work to follow up on. But as I said, it seems many here unfortunately have no clue about stocks and the market, they just speculate wildly and spread opinions that unfortunately, directly and indirectly, cause harm because the wrong conclusions also live on. There is no definitive answer that the price will go all the way down to the issue, or as some believe, that you are almost obliged to sell at the issue price :o Read up a bit on what an issue is, and the different types of processes that have triggered the issues. Feel free to use GOOGLE AI which "unfortunately" gives much better answers than you'll find on the forum here.You naturally have very good points. Many investors with good insight gladly wanted to participate in this share issue for 4.44. And the reason for that was NOT that they would sell out at 4.60. They have much higher expectations. I will be cautious about giving others advice regarding investments, but I still allow myself to ask; why sell now at a price that is 8% lower than yesterday?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 25.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 26.8. | ||
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 25.2. | ||
2025 Q3 -tulosraportti 24.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 |
2026 Q2 -tulosraportti
UUTTA
2 päivää sitten
‧48 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 25.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 26.8. | ||
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 25.2. | ||
2025 Q3 -tulosraportti 24.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·57 min sitten · MuokattuApproximately 20 % more shares have been allocated, if I have understood correctly, at a price 12 % cheaper than the closing price 27.08 of 4,99. Purely mathematically, that should have resulted in a decrease of 2,4 %, which is 12 øre. I.e. price 4,87 before the benefits of the issue are taken into account.
- ·1 t sittenCapitalizing on the share rally: Raises 286 million. Nykode Therapeutics raises 286 million kroner after a strong stock market rally. The share issue was several times oversubscribed.
- ·1 t sittenGood news, the issue was oversubscribed several times. With only 12% discount, the price will probably adjust down a bit. But the finances are strengthened, and the development of the treatments could yield fantastic results. Then the price will probably move further up. Exciting months ahead.
- ·2 t sittenYou must not take everything written here at face value or as a "definitive answer", nor the comment about "down towards the issue price". "It all depends", if it's a distress issue, then yes, the price often but not always goes down towards the issue price, and often even below. If it's an offensive issue, it can go the opposite way. And this issue is more of an "offensive" character than a "Crisis". But there's no definitive answer either on whether it goes up or down based on that. I won't elaborate further here as I also have work to follow up on. But as I said, it seems many here unfortunately have no clue about stocks and the market, they just speculate wildly and spread opinions that unfortunately, directly and indirectly, cause harm because the wrong conclusions also live on. There is no definitive answer that the price will go all the way down to the issue, or as some believe, that you are almost obliged to sell at the issue price :o Read up a bit on what an issue is, and the different types of processes that have triggered the issues. Feel free to use GOOGLE AI which "unfortunately" gives much better answers than you'll find on the forum here.You naturally have very good points. Many investors with good insight gladly wanted to participate in this share issue for 4.44. And the reason for that was NOT that they would sell out at 4.60. They have much higher expectations. I will be cautious about giving others advice regarding investments, but I still allow myself to ask; why sell now at a price that is 8% lower than yesterday?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt